You are about to leave a GSK website
By clicking this link, you will be taken to a website that is independent from GSK. The site you are linking to is not controlled or endorsed by GSK and GSK is not responsible for its content.


Comprehensive biomarker testing in CHB starts with quantitative and qualitative HBsAg.1-4

See why HBsAg is an emerging biomarker in CHB5
Screening and testing for hepatitis B virus infection: CDC recommendations – United States, 2023. Centers for Disease Control and Prevention. March 10, 2023. Accessed March 5, 2026. https://www.cdc.gov/mmwr/volumes/72/rr/rr7201a1.htm
Clinical testing and diagnosis for hepatitis B. Centers for Disease Control and Prevention. January 31, 2025. Accessed March 5, 2026. https://www.cdc.gov/hepatitis-b/hcp/diagnosis-testing/index.html
Understanding your test results. Hepatitis B Foundation. Accessed March 5, 2026. https://www.hepb.org/prevention-and-diagnosis/diagnosis/understanding-your-test-results/#:~:text=Understanding
Additional hepatitis B blood tests. Hepatitis B Foundation. Accessed March 5, 2026. https://www.hepb.org/prevention-and-diagnosis/diagnosis/hepatitis-b-blood-tests
Ghany MG, et al; 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference Faculty. J Hepatol. 2023;79(5):1254-1269.